You are here
Diagnostics and Precision Medicine | Capitol Hill Briefing
AdvaMedDx partnered with the American Association for Cancer Research (AACR) for a briefing on Capitol Hill on June 8, 2015.
Precision medicine is an approach to disease prevention and treatment that takes into account individual differences in people’s genes, environments, and lifestyles. Significant advances in precision medicine are leading to a transformation in the way we diagnose and treat diseases like cancer. Patients with breast, lung, and colorectal cancers, as well as melanomas and leukemias, for instance, routinely undergo molecular testing as part of patient care, enabling physicians to select treatments that improve chances of survival and reduce exposure to adverse effects.
The prospect of applying this concept broadly has been dramatically improved by our ability to use high-throughput sequencing technologies to decipher patient genomes. These and other advances in diagnostic technologies are bringing essential information to bear on treatment decisions, such as identification of how a patient will respond to a specific treatment or a risk prognosis that shapes an individually-tailored health maintenance plan.
The panelists explored recent advances in precision medicine, the challenges in moving the concept of precision medicine into every day clinical practice, and opportunities and implications for the future of this field.
If you missed the event, it can be viewed on Youtube here.
Featured speakers included:
- Kathy Hudson, PhD, Deputy Director for Science, Outreach, and Policy, National Institutes of Health
- Sally Howard, JD, Acting Chief of Staff, US Food and Drug Administration
- Tadd S. Lazarus, MD, Chief Medical Officer, QIAGEN
- Nancy Roach, Founder & Chair of the Board, Fight Colorectal Cancer
- David Solit, MD, Geoffrey Beene Chair; Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, and Co-chair Annual Meeting Program Committee 2014-15, American Association for Cancer Research